Life Sciences


1 to 10 of 413
  • Public contracts: New debarment rules in force Restricted access


    Submitted: 26 February 2015

    The Public Contracts Regulations 2015 came into force on 26 February, including provisions on the debarment of companies convicted of certain offences from public tenders.

  • Information flows: managing the legal risks Restricted access


    Submitted: 26 February 2015

    At this session, we discussed what constitutes “right” information and looked at examples where legal action has been taken against the board for not adequately disclosing or considering information.

  • The demands and pitfalls of antitrust dawn raids

    Conference Call

    Submitted: 12 February 2015

    This call shared experiences from Belgium, France, Germany, Italy, the Netherlands and the UK on what happens when EU or national competition authorities raid a business in the digital age. Built around a likely scenario, the session identifies pitfalls for the unwary and alerts you to practical issues and key differences across our jurisdictions should officials descend on your premises.

  • English contract law case profile – December 2014 Restricted access


    Submitted: 17 December 2014

    The case of Comau UK Limited v Lotus Lightweight Structures Limited (unreported) 27 June 2014 has established that contractual clauses allowing termination for convenience may limit compensation for breach of contract.

  • Latest UPC Rules released prior to public hearings Restricted access


    Submitted: 20 November 2014

    What is expected to be an almost final version of the Rules of Procedure for the Unified Patent Court has been released.

  • Competition Investigations: practical tips Restricted access

    Conference Call

    Submitted: 19 November 2014

    Speakers from across the Simmons & Simmons network cover the key practical considerations arising in Competition Investigations; covering the conduct of internal investigations; handling Dawn Raids and information requests; the criminal cartel offence; immunity and leniency applications; and the co-ordination of multiple country, and multiple regulator, investigations.

  • Digital Health Investment Conference: How do I win in Digital Health? Restricted access


    Submitted: 17 November 2014

    The emerging topic of Digital Health has great promise to reduce inefficiencies in healthcare delivery, reduce costs and make medicine more personalised and precise. This conference aimed to give an insight into opportunities for those looking to invest in digital health and to network with digital health innovators.

  • UK/Germany seek to promote compromise on patent box regimes


    Submitted: 14 November 2014

    Joint UK/German announcement concerning BEPS proposals to deal with preferential IP tax regimes puts continued existence of UK patent box and similar regimes in current form in doubt in medium term.

  • The end of direct sponsorship of healthcare professionals by the medical device industry? Restricted access


    Submitted: 12 November 2014

    MedTech Europe has announced that it proposes to phase out direct sponsorship of healthcare professionals at third party events by their members by 01 January 2018.

  • Episode 429: Collusive strategy triggers damages action

    Video Podcast

    Submitted: 22 October 2014

    Filippo Fioretti and Ombline Ancelin discuss the controversial Italian case finding a collusive strategy in the off label use of a medicine and the damages action it triggered.

1 to 10 of 413